The targeted treatment of implant-associated infections and organ diseases represents great challenges for physicians concerning the demographic change. For systemic treatment, high drug levels are often necessary to achieve ...

We have introduced nanoporous silica as a novel biomaterial. Nanoporous silica is non-toxic and biocompatible. It provides a high surface area and pore volume, uniform and tunable pore sizes and the possibility for chemical ...